Showing results (311-320 of 382) with videos related to
Sort By:
Pageof 39
Gut|December 7, 2006
Expression of a cyclo-oxygenase-2 transgene in murine liver causes hepatitisJun Yu, Alex Y Hui, Eagle S H Chu, et al.Journal of Hepatology|December 3, 2013
Non-alcoholic fatty liver disease: spectral patterns observed from an in vivo phosphorus magnetic resonance spectroscopy studyJill M Abrigo, Jiayun Shen, Vincent W-S Wong, et al.JHEP Reports : Innovation in Hepatology|March 17, 2022
Targeted long-read sequencing reveals clonally expanded HBV-associated chromosomal translocations in patients with chronic hepatitis BNicholas van Buuren, Ricardo Ramirez, Cameron Soulette, et al.Diabetologia|June 1, 2006
Chronic hepatitis B viral infection independently predicts renal outcome in type 2 diabetic patientsA Y S Cheng, A P S Kong, V W S Wong, et al.Liver International : Official Journal of the International Association for the Study of the Liver|August 31, 2017
A new screening strategy for varices by liver and spleen stiffness measurement (LSSM) in cirrhotic patients: A randomized trialGrace L H Wong, Raymond Kwok, Aric J Hui, et al.Gut|January 25, 2023
Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infectionHarry L A Janssen, Jinlin Hou, Tarik Asselah, et al.The Lancet. Gastroenterology & Hepatology|April 13, 2019
Optimisation of the use of APRI and FIB-4 to rule out cirrhosis in patients with chronic hepatitis B: results from the SONIC-B studyMilan J Sonneveld, Willem P Brouwer, Henry L-Y Chan, et al.Alimentary Pharmacology & Therapeutics|July 29, 2017
Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLDS Petta, V W-S Wong, C Cammà, et al.Annals of Internal Medicine|October 3, 2007
Treatment of hepatitis B e antigen positive chronic hepatitis with telbivudine or adefovir: a randomized trialHenry L Y Chan, E Jenny Heathcote, Patrick Marcellin, et al.Journal of Hepatology|December 16, 2014
A CCRK-EZH2 epigenetic circuitry drives hepatocarcinogenesis and associates with tumor recurrence and poor survival of patientsHai Feng, Zhuo Yu, Yuan Tian, et al.Pageof 39